News & Events Year None20202019201820172016201520142013201220112009 05/07/20 REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights 04/30/20 REGENXBIO To Host Conference Call on May 7 to Discuss First Quarter 2020 Financial Results and Recent Operational Highlights 04/28/20 REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 23rd Annual Meeting 04/22/20 REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD 03/31/20 REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder 03/09/20 REGENXBIO to Present at the Barclays Global Healthcare Conference 02/26/20 REGENXBIO Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights Pagination Current page 1 Page 2 Next page next › Last page last »
